STOCK TITAN

Elanco Animal Health grants Rajeev A. Modi stock award

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Elanco Animal Health Inc. (ELAN) reports that Executive Vice President U.S. Pet Health and Global Digital Transformation Rajeev A. Modi received an award of 55.1505 deferred stock units on November 13, 2026, at a reported price of $26.7800 per unit. His reported resulting balance was 10,145.0919 deferred stock units. Each unit represents the right to receive one share of common stock or the cash equivalent; the units settle in cash or shares following termination of employment or during a specified future year under the Executive Deferral and Stock Match Plan.

Insider Modi Rajeev A.
Role SEE REMARKS
Type Security Shares Price Value
Grant/Award Deferred Stock Units F1, F2 55.1505 $26.78 $1K
Holdings After Transaction: Deferred Stock Units — 10,145.0919 units (Direct)
Holdings Before and After: Deferred Stock Units, 10,089.9414 to 10,145.0919 units (Direct)
Footnotes (2)
  1. F1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
  2. F2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.
Deferred stock units awarded 55.1505 deferred stock units Award to Rajeev A. Modi on November 13, 2026
Reported price per deferred stock unit $26.7800 per unit Award reported November 13, 2026
Resulting deferred stock unit balance 10,145.0919 deferred stock units Rajeev A. Modi's reported balance following the award
Deferred Stock Units technical
"Each deferred stock unit represents the right to receive one share"
Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.
Executive Deferral and Stock Match Plan technical
"in accordance with Executive Deferral and Stock Match Plan"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many deferred stock units did ELAN executive Rajeev A. Modi receive?

Rajeev A. Modi, Elanco's Executive Vice President U.S. Pet Health and Global Digital Transformation, received 55.1505 deferred stock units on November 13, 2026, at a reported price of $26.7800 per unit. His reported resulting balance was 10,145.0919 deferred stock units.

How are ELAN deferred stock units settled?

Each deferred stock unit represents the right to receive one share of Elanco common stock or the cash equivalent. The units settle in cash or shares following termination of employment or during a specified future year under the Executive Deferral and Stock Match Plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Modi Rajeev A.

(Last)(First)(Middle)
C/O ELANCO ANIMAL HEALTH INCORPORATED
450 ELANCO CIRCLE

(Street)
INDIANAPOLIS INDIANA 46221

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Elanco Animal Health Inc [ ELAN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
SEE REMARKS
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/13/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Deferred Stock Units(1)11/13/2026A55.1505 (2) (2)Common Stock55.1505$26.7810,145.0919D
Explanation of Responses:
1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.
Remarks:
Executive Vice President U.S. Pet Health and Global Digital Transformation
/s/ Amy C. Seidel, as Attorney-in-Fact for Rajeev A. Modi11/17/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading